NEW YORK, Nov 28 – Motorola said Tuesday that it would use Compugen’s chip design services in the development and manufacture of some of its DNA biochips.
" We believe that Compugen's LEADS technology platform and DNA chip design tools offer significant potential to enhance the utility and applications for DNA biochips,” said Nicholas Naclerio, vice president and general manager of Motorola's BioChip Systems business, in a statement.
This marks the first commercial agreement for Compugen's biochip design services based upon its LEADS platform and proprietary DNA chip design tools.
LEADS is an algorithm-driven bioinformatics platform for the analysis and mining of genomic, expressed, and protein sequence data.
As part of the deal, Motorola's customers would get access to related bioinformatic services through a link to LabOnWeb.com, Compugen's research engine for genomic, proteomic, and transcriptomic analysis. These bioinformatic services will also include exclusive information obtained from Compugen's proprietary databases.
Financial terms of the agreement were not disclosed.